semaglutide 7.2 Novo Nordisk announced headline results from STEP UP, a phase IIIb trial investigating subcutaneous mg for obesity The FDA has approved a

A different mechanism

A recent study 40 showed UA to regulate the transmission of alpha-synuclein in both animal and cellular Parkinsonian models, with a reduction in dopaminergic cell damage

It's not really changing the course of the disease

Maintaining adequate levels of GSH is key to help break the ferroptosis cycle and slow down menopausal skin aging

Ilyas, Z., Chaudhary, R., Devi, S., & Bhandari, V

The risks of compounded "semaglutide" made with illicit foreign API FDA has issued multiple alerts, the latest on July 29th, warning patients and healthcare professionals about the dangers of these knockoff drugs, including reports of patients overdosing by mistakenly administering five to 20 times the intended dose and requiring hospitalization